Green light to continue LPS trial

Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has received ethics and competent authority approval to commence its Lipopolysaccharide (LPS) human challenge clinical trial for PO...

See more

NICE recommended Opdivo as post-surgery treatment

The therapy will be used for specific muscle invasive urothelial cancer patients Bristol Myers Squibb has announced that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination recommending Opdivo (n...

See more

Another Success of MAKROMED LLC!

Ellab Diagnostics, one of the clinics designed by MAKROMED LLC, was inaugurated on 20.04.2022. The clinics has a fully equipped laboratory and modern medical equipment that meets all international requirements. It is a great success to ensure that al...

See more